American BriVision Reports Completion of ABV-1505 Phase II Part I Clinical Trial for Treatment of Adult ADHD

NEXT STORY
RedHill Biopharma Publishes Positive IBS-D Phase 2 Study Data in The American Journal of Gastroenterology
PREV STORY
electroCore Announces Non-Invasive Vagus Nerve Stimulation Clinical Update Publication in Cephalalgia
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AntriaBio Announces Selection of Lead Oral Plasma Kallikrein Inhibitor Candidates for the Treatment of Diabetic Retinopathy, Diabetic Macular Edema and Hereditary Angioedema

LOUISVILLE, Colo., Oct. 17, 2017 (GLOBE NEWSWIRE) -- AntriaBio, Inc. (“AntriaBio” or the “Company”) ...

author_avatar
NASDAQ Market News

PRA Holdings, Inc. Announces Completion of Cash Tender Offer for its 9.500% Senior Notes Due 2023

RALEIGH, N.C., March 17, 2016 (GLOBE NEWSWIRE) -- PRA Holdings, Inc. (“PRA Holdings”), a ...

author_avatar
NASDAQ Market News

One in five from 2001 – 2008 U.S. military sample have obesity; Veterans as likely to have obesity as civilians, study shows

SILVER SPRING, Md., June 27, 2016 (GLOBE NEWSWIRE) -- Despite being held to stringent ...

author_avatar
NASDAQ Market News